Enduring businesses. Outsized impact.
We are a diverse group of modern-day cowboys building industry-impact businesses for a healthier world.
Who We Are
We are not a Private Equity Group, Venture Fund/Studio or a Family Office Fund; nor do we operate businesses. We identify large, untapped opportunities and then build category leaders.
Identify
The best teams in each domain
Provide
Capital and operating discipline
Help
Founders scale and compound globally
NDude Investments
We partner with a select group of founders to build industry impact players and maximize shareholder value.
Nutriventia
Science-led nutraceutical ingredients company specializing in clinically validated, proprietary branded ingredients.
Visit site
SuperMush
Develops functional mushroom supplements supporting focus immunity energy with clean science backed formulations daily use.
Visit site
Buoy
Unflavored ocean electrolytes and 87+ trace minerals that turn any drink into clinically proven hydration.
Visit site
Third Eye Cacao
Creates ceremonial cacao blends supporting wellness rituals mindfulness energy through ethically sourced premium cacao products.
Visit site
OneSource CDMO
End-to-end pharmaceutical and biologics CDMO delivering drug development and manufacturing solutions with regulatory excellence.
Visit site
A4 Hospital
Premier multispecialty hospital delivering compassionate, advanced, patient-centric care across medical specialties in Chennai.
Visit site
In the News
Press release
Health & Wellness focused fund NDude Labs invests $3 million in Series A for SuperMush to Accelerate Growth of Functional Wellness Brand
The new capital will support SuperMush’s product expansion, deepen investment in high-efficacy formulations, and strengthen the team and infrastructure needed to reach more customers.
Read the announcement
Press release
NDude Labs Invests in Nutraceutical Ingredients Company Nutriventia to Support Global Expansion
Capital will fund clinical R&D, scale the branded ingredient portfolio and proprietary delivery platform across global markets, and establish a dedicated US commercial team.
Read the announcement
Start the Conversation
If your vision aligns with ours, we'd like to hear from you.